Related Products
- 847502-83-4Benzonitrile,3,4-difluoro-2-methyl-
- 84750-88-9Dimethyl perfluoro-1,10-decanedicarboxylate
- 84752-61-4PYRIDINIUM M-NITROBENZENESULFONATE
- 84-75-31,2-Benzenedicarboxylicacid, 1,2-dihexyl ester
- 84753-06-0Tetrasodium 4,4-bis((1-hydroxy-4-sulphonato-2-naphthyl)azo)(1,1-biphenyl)-2,2-disulphonate
- 847547-91-54-Quinolinecarboxylicacid, 2-chloro-3-hydroxy-
- 847551-25-17H-Pyrrolo[2,3-d]pyrimidine,7-[3,5-bis-O-[(2,4-dichlorophenyl)methyl]-2-C-methyl-b-D-ribofuranosyl]-4-chloro-5-iodo-
- 847551-48-87H-Pyrrolo[2,3-d]pyrimidine,4-chloro-5-iodo-7-(2-C-methyl-b-D-ribofuranosyl)-
- 847551-49-97H-Pyrrolo[2,3-d]pyrimidin-4-amine,5-iodo-7-(2-C-methyl-b-D-ribofuranosyl)-
- 84755-29-3Ethanone, 1-[2-(methylthio)-5-pyrimidinyl]-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Delanzomib |
EINECS | N/A |
| CAS No. | 847499-27-8 | Density | 1.207 |
| PSA | 138.76000 | LogP | 2.60570 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C21H28BN3O5 | Boiling Point | N/A |
| Molecular Weight | 413.281 | Flash Point | N/A |
| Transport Information | N/A | Appearance | white powder |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
CEP 18770;CEP-18770; |
Article Data | 5 |
Delanzomib Specification
Delanzomib is an orally active proteasome inhibitor. Delanzomib has been shown to down-modulate NF-κB, induce apoptosis, inhibit angiogenesis and M-CSF-RANKL-induced osteoclastogenesis.
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 847499-27-8
CEP-18770
